S-phase fraction as response marker in patients with chronic myeloid leukemia.
Tripathi
Anil Kumar
AK
Tripathi
Payal
P
Ahmad
Rizwan
R
Chaudhary
Parijat Deb
PD
Verma
Shailendra Kumar
SK
D001549:Benzamides; D014408:Biomarkers, Tumor / Q000378:metabolism*; D016022:Case-Control Studies; D004247:DNA / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D020869:Gene Expression Profiling; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood* / Q000175:diagnosis*; D008297:Male; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D016196:S Phase
D001549:Benzamides; D014408:Biomarkers, Tumor; D010879:Piperazines; D011743:Pyrimidines; D012333:RNA, Messenger; D000068877:Imatinib Mesylate; D004247:DNA